Prognostic factors and treatment effect in the CHIMES study
© 2015 by National Stroke Association. Background: Stroke trials often analyze patients with heterogeneous prognoses using a single definition of outcome, which may not be applicable to all subgroups. We aimed to evaluate the treatment effects of MCL601 among patients stratified by prognosis in the...
محفوظ في:
المؤلفون الرئيسيون: | Siwaporn Chankrachang, Jose C. Navarro, Deidre A.De Silva, Somchai Towanabut, Carlos L. Chua, Chun Fan Lee, Narayanaswamy Venketasubramanian, K. S.Lawrence Wong, Marie Germaine Bousser, Christopher L.H. Chen |
---|---|
التنسيق: | دورية |
منشور في: |
2018
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84930574017&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/54818 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Prognostic factors and treatment effect in the CHIMES study
بواسطة: Siwaporn Chankrachang, وآخرون
منشور في: (2018) -
CHIMES-I: Sub-group analyzes of the effects of NeuroAiD according to baseline brain imaging characteristics among patients randomized in the CHIMES study
بواسطة: Navarro, J.C., وآخرون
منشور في: (2016) -
Effect of Combined Treatment with MLC601 (NeuroAiDTM) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies
بواسطة: Suwanwela N.C., وآخرون
منشور في: (2019) -
Durability of the beneficial effect of MLC601 (NeuroAiD™) on functional recovery among stroke patients from the Philippines in the CHIMES and CHIMES-E studies
بواسطة: Navarro, J.C, وآخرون
منشور في: (2020) -
A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study)
بواسطة: N. Venketasubramanian, وآخرون
منشور في: (2018)